{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:55:31Z","timestamp":1791939331006,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s40122-023-00539-5","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T19:01:26Z","timestamp":1689447686000},"page":"1121-1134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-6206","authenticated-orcid":false,"given":"Amber N.","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saveen","family":"Sall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Koepnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan C.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"key":"539_CR1","unstructured":"Major Depression [Internet]. National Institute of Mental Health (NIMH). [cited 2023 Jan 22]. Available from https:\/\/www.nimh.nih.gov\/health\/statistics\/major-depression"},{"issue":"7526","key":"539_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/515180a","volume":"515","author":"K Smith","year":"2014","unstructured":"Smith K. Mental health: a world of depression. Nature. 2014;515(7526):180\u20131.","journal-title":"Nature"},{"issue":"6","key":"539_CR3","first-page":"116","volume":"13","author":"VL Ruberto","year":"2020","unstructured":"Ruberto VL, Jha MK, Murrough JW. Pharmacological treatments for patients with treatment-resistant depression. Pharm Basel Switz. 2020;13(6):116.","journal-title":"Pharm Basel Switz"},{"issue":"3","key":"539_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.rpsm.2018.09.002","volume":"12","author":"C Alamo","year":"2019","unstructured":"Alamo C, Garc\u00eda-Garcia P, Lopez-Mu\u00f1oz F, Zaragoz\u00e1 C. Tianeptine, an atypical pharmacological approach to depression. Rev Psiquiatr Salud Ment. 2019;12(3):170\u201386.","journal-title":"Rev Psiquiatr Salud Ment"},{"issue":"5","key":"539_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00131746-200409000-00006","volume":"10","author":"SH Preskorn","year":"2004","unstructured":"Preskorn SH. Tianeptine: a facilitator of the reuptake of serotonin and norepinephrine as an antidepressant? J Psychiatr Pract. 2004;10(5):323.","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"539_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/00952990.2021.1938101","volume":"47","author":"W Rushton","year":"2021","unstructured":"Rushton W, Rivera J. Tianeptine: a new frontier in surveillance and understanding through social media. Am J Drug Alcohol Abuse. 2021;47(4):411\u20133.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"539_CR7","unstructured":"Nutrition C for FS and A. Tianeptine in dietary supplements. FDA [Internet]. 2020 Jun 22 [cited 2023 Mar 4]; Available from https:\/\/www.fda.gov\/food\/dietary-supplement-products-ingredients\/tianeptine-dietary-supplements"},{"key":"539_CR8","doi-asserted-by":"crossref","unstructured":"Bailey SJ, Almatroudi A, Kouris A. Tianeptine: an atypical antidepressant with multimodal pharmacology. Curr Psychopharmacol [Internet]. 2018 Jan 2 [cited 2023 Mar 5];6(2). Available from http:\/\/www.eurekaselect.com\/152697\/article","DOI":"10.2174\/2211556006666170525154616"},{"issue":"7","key":"539_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jat\/bky023","volume":"42","author":"EL Bakota","year":"2018","unstructured":"Bakota EL, Samms WC, Gray TR, Oleske DA, Hines MO. Case reports of fatalities involving tianeptine in the United States. J Anal Toxicol. 2018;42(7):503\u20139.","journal-title":"J Anal Toxicol"},{"issue":"4","key":"539_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00952990.2021.1904408","volume":"47","author":"KE Smith","year":"2021","unstructured":"Smith KE, Rogers JM, Strickland JC, Epstein DH. When obscurity becomes a trend: social-media descriptions of tianeptine use and associated atypical drug use. Am J Drug Alcohol Abuse. 2021;47(4):455\u201366.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"539_CR11","unstructured":"Tianeptine: new description of the mechanism of action and change of technical data sheet. Elsevier Enhanced Reader [Internet]. [cited 2023 Mar 19]. Available from https:\/\/reader.elsevier.com\/reader\/sd\/pii\/S217350502100011X?token=0A6A7A2CB1D74049B774D95FB8891A2439596A9B08A7FE3707DB14FFE902CAA6231D91F78CF398C91331846CA8EC2EB8&originRegion=us-east-1&originCreation=20230319173426"},{"issue":"7","key":"539_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","volume":"24","author":"S Moriguchi","year":"2019","unstructured":"Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolic levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24(7):952\u201364.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"539_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.emc.2022.01.001","volume":"40","author":"AE Michienzi","year":"2022","unstructured":"Michienzi AE, Borek HA. Emerging agents of substance use\/misuse. Emerg Med Clin North Am. 2022;40(2):265\u201381.","journal-title":"Emerg Med Clin North Am"},{"issue":"10","key":"539_CR14","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/npp.2017.60","volume":"42","author":"BA Samuels","year":"2017","unstructured":"Samuels BA, Nautiyal KM, Kruegel AC, Levinstein MR, Magalong VM, Gassaway MM, et al. The behavioral effects of the antidepressant tianeptine require the mu-opioid receptor. Neuropsychopharmacology. 2017;42(10):2052\u201363.","journal-title":"Neuropsychopharmacology"},{"key":"539_CR15","unstructured":"Commissioner O of the. Tianeptine products linked to serious harm, overdoses, death. FDA [Internet]. 2022 Feb 10 [cited 2023 Jan 22]. Available from https:\/\/www.fda.gov\/consumers\/consumer-updates\/tianeptine-products-linked-serious-harm-overdoses-death"},{"key":"539_CR16","unstructured":"Synthetic Drugs | CADCA [Internet]. [cited 2022 Dec 29]. Available from https:\/\/www.cadca.org\/synthetic-drugs#_ftn6"},{"key":"539_CR17","unstructured":"Stovall M. Mark Stovall: gas station drugs: the hidden danger around every corner [internet]. The Dispatch. 2022 [cited 2022 Dec 29]. Available from https:\/\/cdispatch.com\/opinions\/2022-10-14\/mark-stovall-gas-station-drugs-the-hidden-danger-around-every-corner\/"},{"key":"539_CR18","unstructured":"Gas Station Drugs\u2014Southern Medical Association [Internet]. 2022 [cited 2022 Dec 29]. Available from https:\/\/sma.org\/gas-station-drugs\/"},{"key":"539_CR19","unstructured":"Warren A. State health officials sounding alarm on \u2018gas station heroin\u2019 [internet]. https:\/\/www.wlbt.com. 2022 [cited 2022 Dec 29]. Available from https:\/\/www.wlbt.com\/2022\/03\/25\/state-health-officials-sounding-alarm-gas-station-heroin\/"},{"key":"539_CR20","unstructured":"Alyssa. What is gas station dope? Banyan Pompano [Internet]. Banyan Treatment Center. 2022 [cited 2022 Dec 29]. Available from https:\/\/www.banyantreatmentcenter.com\/2022\/05\/31\/what-is-gas-station-dope-pompano\/"},{"key":"539_CR21","unstructured":"Nikki. Gas station drugs can contain addictive substances hidden in plain sight [Internet]. APCBham. 2022 [cited 2022 Dec 29]. Available from https:\/\/apcbham.org\/2022\/06\/06\/gas-station-drugs-can-contain-addictive-substances-hidden-in-plain-sight\/"},{"key":"539_CR22","unstructured":"Jorandby. Update on \u201cGas Station Heroin\u201d and other legal drugs. Psychology Today [Internet]. 2022 [cited 2022 Dec 29]. Available from https:\/\/www.psychologytoday.com\/us\/blog\/use-your-brain\/202208\/update-gas-station-heroin-and-other-legal-drugs"},{"issue":"6","key":"539_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.psym.2018.07.006","volume":"59","author":"R Lauhan","year":"2018","unstructured":"Lauhan R, Hsu A, Alam A, Beizai K. Tianeptine abuse and dependence: case report and literature review. Psychosomatics. 2018;59(6):547\u201353.","journal-title":"Psychosomatics"},{"issue":"3","key":"539_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/02791072.2018.1438687","volume":"50","author":"J Springer","year":"2018","unstructured":"Springer J, Cuba\u0142a WJ. Tianeptine abuse and dependence in psychiatric patients: a review of 18 case reports in the literature. J Psychoactive Drugs. 2018;50(3):275\u201380.","journal-title":"J Psychoactive Drugs"},{"issue":"2\u20133","key":"539_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.forsciint.2007.03.035","volume":"170","author":"P Proen\u00e7a","year":"2007","unstructured":"Proen\u00e7a P, Teixeira H, Pinheiro J, Monsanto PV, Vieira DN. Fatal intoxication with tianeptine (Stablon). Forensic Sci Int. 2007;170(2\u20133):200\u20133.","journal-title":"Forensic Sci Int"},{"issue":"6","key":"539_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jat\/bkx034","volume":"41","author":"SK Dempsey","year":"2017","unstructured":"Dempsey SK, Poklis JL, Sweat K, Cumpston K, Wolf CE. Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine. J Anal Toxicol. 2017;41(6):547\u201350.","journal-title":"J Anal Toxicol"},{"issue":"251","key":"539_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.119412","volume":"15","author":"OA Abdullatef","year":"2021","unstructured":"Abdullatef OA, Morshedy S, Khalifa YM, Talaat W. Spectrofluorimetric determination of tianeptine using its quenching effect on vilazodone. Spectrochim Acta A Mol Biomol Spectrosc. 2021;15(251): 119412.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"2","key":"539_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/PRA.0000000000000448","volume":"26","author":"A Karim","year":"2020","unstructured":"Karim A, Ioannou C. Tianeptine abuse leading to an episode of psychosis: a case report and literature review. J Psychiatr Pract. 2020;26(2):146\u20138.","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"539_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1556-4029.2008.00754.x","volume":"53","author":"AL P\u00e9lissier-Alicot","year":"2008","unstructured":"P\u00e9lissier-Alicot AL, Gavaudan G, Bartoli C, Kintz P, Piercecchi-Marti MD, Desfeux J, et al. Planned complex suicide: an unusual case. J Forensic Sci. 2008;53(4):968\u201370.","journal-title":"J Forensic Sci"},{"issue":"4","key":"539_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/ADM.0000000000000490","volume":"13","author":"P Trowbridge","year":"2019","unstructured":"Trowbridge P, Walley AY. Use of buprenorphine-naloxone in the treatment of tianeptine use disorder. J Addict Med. 2019;13(4):331\u20133.","journal-title":"J Addict Med"},{"issue":"7","key":"539_CR31","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s00213-022-06093-w","volume":"239","author":"TR Baird","year":"2022","unstructured":"Baird TR, Akbarali HI, Dewey WL, Elder H, Kang M, Marsh SA, et al. Opioid-like adverse effects of tianeptine in male rats and mice. Psychopharmacology. 2022;239(7):2187\u201399.","journal-title":"Psychopharmacology"},{"issue":"3","key":"539_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2165\/00023210-200115030-00006","volume":"15","author":"AJ Wagstaff","year":"2001","unstructured":"Wagstaff AJ, Ormrod D, Spencer CM. Tianeptine. CNS Drugs. 2001;15(3):231\u201359.","journal-title":"CNS Drugs"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-023-00539-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T13:20:12Z","timestamp":1692710412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-023-00539-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s40122-023-00539-5","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"3 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}